Provided by Tiger Trade Technology Pte. Ltd.

Processa Pharmaceuticals, Inc.

2.08
-0.0650-3.03%
Post-market: 2.200.1200+5.77%18:17 EDT
Volume:75.96K
Turnover:157.17K
Market Cap:5.81M
PE:-0.37
High:2.22
Open:2.21
Low:2.00
Close:2.15
52wk High:14.24
52wk Low:1.67
Shares:2.79M
Float Shares:2.68M
Volume Ratio:1.76
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5949
EPS(LYR):-96.8176
ROE:-464.20%
ROA:-156.79%
PB:-18.31
PE(LYR):-0.02

Loading ...

Processa Net Loss Narrows to $3.27 Million in Q2 2026

Reuters
·
Aug 15

Processa Pharmaceuticals Held Annual Shareholder Meeting, Quorum Met by Proxy or in Person

Reuters
·
Aug 05

Processa Pharmaceuticals Director Sheila Gujrathi Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Processa Pharmaceuticals acquires Vidya Therapeutics in stock-for-stock deal

TIPRANKS
·
Jul 29

Processa Pharmaceuticals, Inc. Announces Acquisition of Vidya Therapeutics, Inc. and Approximately $200 Million Concurrent Private Placement to Advance Btk Inhibitor, Vt-7208, in Multiple Disease Areas

THOMSON REUTERS
·
Jul 29

Processa Pharma President of R&D David Young Acquires 2,531 Common Shares Worth $4,884.83

Reuters
·
Jul 02

Processa Pharmaceuticals announces annual shareholder meeting

Reuters
·
Jun 19

Processa Pharma Chief Administrative Officer Wendy Guy acquires 2,118 common shares worth $4,701.96

Reuters
·
Jun 17

Processa R&D President David Young reports purchase of 1,786 Processa shares for $4,590.02

Reuters
·
Jun 02

Processa CFO Russell Skibsted acquires 2,292 common shares for $5,890.44

Reuters
·
Jun 02

Processa Pharma CEO George Ng acquires 2,129 common shares for $5,471.53

Reuters
·
Jun 02

Processa chief business-strategy officer Patrick Lin acquires 1,582 shares for $4,065.74

Reuters
·
Jun 02

Processa Pharmaceuticals Chief Administrative Officer Wendy Guy acquires 1,829 common shares for $4,701.53

Reuters
·
Jun 02

Processa CEO George Ng buys 1,843 shares for $5,472.71

Reuters
·
May 20

Processa R&D President David Young acquires 1,545 shares worth $4,588.65

Reuters
·
May 20

Processa Chief Business-Strategy Officer Patrick Lin acquires 1,369 shares for $4,065.93

Reuters
·
May 20

Processa Pharma CAO Wendy Guy acquires 1,583 common shares worth $4,702.51

Reuters
·
May 20

Processa CFO Russell Skibsted acquires 1,984 shares for $5,892.48

Reuters
·
May 20

Processa Pharmaceuticals Q1 net loss widens to $3.38 million

Reuters
·
May 08

Processa R&D President David Young acquires 1,706 shares for $4,589.14

Reuters
·
May 02